Loading
NASDAQHealthcareMedical - Instruments & Supplies
Latest quote
$0.3165
−$0.0229 · -6.75%
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
Latest quote
$0.3165
−$0.0229 · -6.75%
Regular session · ET · Market data may be delayed.
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
Regular session · ET · Market data may be delayed.
GoAI Score
Hold
Valuation
65
Undervalued
Sentiment
56
Mixed
Risk
69
High Risk
Momentum
21
Weakening
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
NEXGEL, Inc. is a company that develops and produces advanced hydrogels and gels. These materials are characterized by their significant water content, aqueous polymer composition, and electron beam cross-linking technology. NEXGEL's diverse product range serves crucial applications across several sectors, including wound care management, medical diagnostic tools, transdermal drug delivery systems, and cosmetic formulations. The company was founded in 1997 and operated under the name AquaMed Technologies, Inc. until it rebranded as NEXGEL, Inc. in November 2019. Its headquarters are located in Langhorne, Pennsylvania.
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 11.42M USD | 8.69M USD | 4.09M USD | 2.05M USD | 1.55M USD |
| Cost of goods sold | 6.91M USD | 5.94M USD | 3.72M USD | 1.79M USD | 1.54M USD |
| Gross profit | 4.51M USD | 2.75M USD | 374K USD | 256K USD | 8K USD |
| Research and development | 2K USD | 78K USD | 103K USD | 367K USD | 31K USD |
| Selling, general, and administrative | 7.86M USD | 5.91M USD | 3.4M USD | 2.82M USD | 2.41M USD |
| Operating expenses | 7.86M USD | 6.3M USD | 3.85M USD | 3.6M USD | 2.58M USD |
| Interest expense | 34K USD | 81K USD | 15K USD | 1.34M USD | 2M USD |
| Depreciation and amortization | 740K USD | 480K USD | 443K USD | 301K USD | 138K USD |
| Operating income | −3.35M USD | −3.55M USD | −3.48M USD | −3.35M USD | −2.57M USD |
| Net income | −3M USD | −3.28M USD | −3.16M USD | −4.75M USD | −4.31M USD |
Company facts updated Sep 7, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Extended Market ETFVXF
U.S. Micro Cap Portfolio ETFDFMC
Dimensional - US Small Cap ETFDFASAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
